- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Novogen Ltd+ Add to Watchlist
NVGN:US4.5500 USD 0.7800 20.69%
As of 20:10:00 ET on 03/27/2015.
Company Profile for Novogen Ltd (NVGN)
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
Key Executives for Novogen Ltd (NVGN)
|Graham Edmund KellyChairman/CEO||David BrownChief Scientific Officer|
|Cristyn HumphreysCOO:Administration & Finance||W Andrew HeatonVP:Drug Discovery|
|Justine StehnDir:ATM Program||Stephen PalmerDir:Degenerative Disease Program|
|Lionel MateoSecretary||Kimberley LilischkisManager:Clinical & Regulatory Affairs|